|
⚲
|
| Keyboard |
| Zuerblis Kenneth J
✚
|
|
|---|---|
| CIK # | 0001007923 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001007923] | |
| 4 | [0001007923] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Stemline Therapeutics Inc | |
| Zuerblis Kenneth J | |
| Savient Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Stemline Therapeutics Inc STML
Common Stock
|
2020-06-10 | Tender | 60,121 | ||
|
Stemline Therapeutics Inc STML
Stock Option (right to buy) · derivative
|
2020-06-10 | Disposed to issuer | 34,000 | ||
|
Stemline Therapeutics Inc STML
Stock Option (right to buy) · derivative
|
2020-06-10 | Disposed to issuer | 24,000 | ||
|
Stemline Therapeutics Inc STML
Common Stock
|
2019-06-25 | Grant | 15,000 | $0.00 | |
|
Stemline Therapeutics Inc STML
Common Stock
|
2018-06-21 | Grant | 13,158 | $0.00 | |
|
Stemline Therapeutics Inc STML
Stock Options (right to buy) · derivative
|
2017-06-19 | Grant | 24,000 | $0.00 | |
|
Stemline Therapeutics Inc STML
Common Stock
|
2017-06-19 | Grant | 10,000 | $0.00 | |
|
Stemline Therapeutics Inc STML
Stock Options (right to buy) · derivative
|
2016-05-25 | Grant | 34,000 | $0.00 | |
|
Stemline Therapeutics Inc STML
Common Stock
|
2015-06-23 | Grant | 10,000 | $0.00 | |
|
Stemline Therapeutics Inc STML
Stock Options (right to buy) · derivative
|
2015-06-23 | Grant | 24,000 | $0.00 | |
|
Stemline Therapeutics Inc STML
Common Stock
|
2014-09-02 | Buy | 1,000 | $11.14 | 11,140 |
|
Stemline Therapeutics Inc STML
Stock Options (right to buy) · derivative
|
2014-06-19 | Grant | 20,000 | $0.00 | |
|
Stemline Therapeutics Inc STML
Stock Options (right to buy) · derivative
|
2013-06-19 | Grant | 20,000 | $0.00 | |
|
Stemline Therapeutics Inc STML
Common Stock
|
2013-05-30 | Buy | 200 | $16.38 | 3,276 |
|
Stemline Therapeutics Inc STML
Common Stock
|
2013-05-30 | Buy | 700 | $16.38 | 11,466 |
|
Stemline Therapeutics Inc STML
Common Stock
|
2013-05-29 | Buy | 600 | $15.85 | 9,510 |
|
Stemline Therapeutics Inc STML
Common Stock
|
2013-05-29 | Buy | 500 | $15.86 | 7,930 |
|
Stemline Therapeutics Inc STML
Common Stock
|
2013-05-29 | Buy | 1,000 | $15.86 | 15,860 |
|
Savient Pharmaceuticals Inc SVNT
Option to Purchase Common Stock, $.01 par value · derivative
|
2012-02-01 | Grant | 100,000 | $2.26 | 226,000 |